Suppr超能文献

用于法医用途的短串联重复序列(STR)验证:荧光多重STR系统的性能测试以及真实和模拟法医样本分析

Validation of short tandem repeats (STRs) for forensic usage: performance testing of fluorescent multiplex STR systems and analysis of authentic and simulated forensic samples.

作者信息

Moretti T R, Baumstark A L, Defenbaugh D A, Keys K M, Smerick J B, Budowle B

机构信息

FBI Laboratory, FBI Academy, Quantico, VA 22135, USA.

出版信息

J Forensic Sci. 2001 May;46(3):647-60.

Abstract

The amplification and typing conditions for the 13 core CODIS loci and their forensic applicability were evaluated. These loci are CSF1PO, FGA, TH01, TPOX, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, and D21S11. Results were obtained using the multiplex STR systems AmpFlSTR Profiler Plus and AmpFlSTR COfiler (Applied Biosystems, Foster City, CA), GenePrint PowerPlex (Promega Corporation, Madison, WI), and subsets of these kits. For detection of fluorescently labeled amplified products, the ABI Prism 310 Genetic Analyzer, the ABI Prism 377 DNA Sequencer, the FMBIO II Fluorescent Imaging Device, and the Fluorlmager were utilized. The following studies were conducted: (a) evaluation of PCR parameter ranges required for adequate performance in multiplex amplification of STR loci, (b) determination of the sensitivity of detection of the systems, (c) characterization of non-allelic PCR products, (d) evaluation of heterozygous peak intensities, (e) determination of the relative level of stutter per locus, (f) determination of stochastic PCR thresholds, (g) analysis of previously typed case samples, environmentally insulted samples, and body fluid samples deposited on various substrates, and (h) detection of components of mixed DNA samples. The data demonstrate that the commercially available multiplex kits can be used to amplify and type STR loci successfully from DNA derived from human biological specimens. There was no evidence of false positive or false negative results and no substantial evidence of preferential amplification within a locus. Although at times general balance among loci labeled with the same fluorophore was not observed, the results obtained were still valid and robust. Suggested criteria are provided for determining whether a sample is derived from a single source or from more than one contributor. These criteria entail the following: (a) the number of peaks at a locus, (b) the relative height of stutter products, and (c) peak height ratios. Stochastic threshold levels and the efficiency of non-templated nucleotide addition should be considered when evaluating the presence of mixtures or low quantity DNA samples. Guidelines, not standards, for interpretation should be developed to interpret STR profiles in cases, because there will be instances in which the standards may not apply. These instances include (a) a primer binding site variant for one allele at a given locus, (b) unusually high stutter product, (c) gene duplication, and (d) translocation.

摘要

对13个核心联合DNA索引系统(CODIS)基因座的扩增和分型条件及其法医学适用性进行了评估。这些基因座包括CSF1PO、FGA、TH01、TPOX、vWA、D3S1358、D5S818、D7S820、D8S1179、D13S317、D16S539、D18S51和D21S11。使用多重短串联重复序列(STR)系统AmpFlSTR Profiler Plus和AmpFlSTR COfiler(应用生物系统公司,加利福尼亚州福斯特城)、GenePrint PowerPlex(普洛麦格公司,威斯康星州麦迪逊)以及这些试剂盒的子集获得了结果。为了检测荧光标记的扩增产物,使用了ABI Prism 310基因分析仪、ABI Prism 377 DNA测序仪、FMBIO II荧光成像设备和荧光成像仪。进行了以下研究:(a)评估STR基因座多重扩增中获得充分性能所需的PCR参数范围;(b)确定各系统的检测灵敏度;(c)对非等位基因PCR产物进行表征;(d)评估杂合峰强度;(e)确定每个基因座的相对拖尾水平;(f)确定随机PCR阈值;(g)分析先前分型的案件样本、受环境影响的样本以及沉积在各种底物上的体液样本;(h)检测混合DNA样本的成分。数据表明,市售的多重试剂盒可成功地从人类生物标本衍生的DNA中扩增和分型STR基因座。没有假阳性或假阴性结果的证据,也没有基因座内优先扩增的实质性证据。尽管有时未观察到用相同荧光团标记的基因座之间的总体平衡,但获得的结果仍然有效且可靠。提供了用于确定样本是来自单一来源还是来自多个贡献者的建议标准。这些标准包括:(a)一个基因座处的峰数;(b)拖尾产物的相对高度;(c)峰高比。在评估混合物或低量DNA样本的存在时,应考虑随机阈值水平和非模板核苷酸添加的效率。应制定解释指南而非标准来解释案件中的STR图谱,因为会存在标准可能不适用的情况。这些情况包括:(a)给定基因座上一个等位基因的引物结合位点变异;(b)异常高的拖尾产物;(c)基因重复;(d)易位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验